- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens launches CT stroke package
Other headlines: Volcano enter thrombus aspiration nicheFonar writes bottom line in black
Siemens launches CT stroke package
A CT Neuro Engine to assess stroke debuted in the Siemens booth May 18 at the American Society of Neuroradiology in Vancouver, BC. The Neuro Engine processes data acquired using a volume perfusion technique. Data are obtained over a 15-cm Adaptive 4D Spiral brain scan. Scans can be performed on any of the company's Definition Flash, Definition, and Definition AS scanners, including the newly introduced 20-slice configuration. The fully automated neuro perfusion tools support quantitative volume evaluation for differential diagnosis of ischemic stroke and simultaneous multislice processing.
Volcano enter thrombus aspiration niche
Vascular specialist Volcano has struck an exclusive worldwide agreement to distribute the Xtract thrombus aspiration catheter, manufactured by Lumen Biomedical. The firm has begun selling the catheter in the U.S. and Europe, marking its entry into a $70-plus million per year market for products used to suction out thrombus, according to a Volcano estimate. Xtract is FDA-cleared and CE-Marked for use in coronary and peripheral vessels. Its single-lumen design maximizes cross-sectional area for thrombus suction. A circular, right-angle tip allows close-up access to clots. A curved, directional tip enables a full sweep of the vessel.
Fonar writes bottom line in black
MR maverick Fonar turned a $730,000 profit in the third quarter, compared with a $2.7 million loss in the year-earlier period. Driving the gain was a 39.5% boost in revenue to $11.3 million compared with $8.1 million for the quarter ending March 31, 2008. This is the second quarter in a row in which Fonar was profitable, according to the company. Product sales rose dramatically, leaping 162.2% to $6.2 million from $2.3 million during the year-earlier quarter. Company president and chairman Dr. Raymond Damadian also credited aggressive cost-cutting and emphasis on "selling scans" at clinical sites managed by its wholly owned subsidiary HMCA (Health Management Corporation of America) for the healthy bottom line.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
